STORM Therapeutics

STORM Therapeutics is a University of Cambridge spin-out using RNA epigenetics to develop first-in-class drugs in oncology and other diseases.

Palm tree branches bending as storm clouds approach

Biotech

Storm secures $56M series C, launches ph. 2 sarcoma trial

Former Fierce 15 honoree Storm Therapeutics has closed a $56 million series C financing and launched a Phase 2 trial for sarcoma patients.

Will Maddox Apr 16, 2026 10:12am

parasailing over clouds in Salzburg Austria

Incyte, FDA, Sun Pharma and more—Chutes & Ladders

Jun 27, 2025 8:30am

hawaii parasail ocean

20-year Novo vet lands first CEO role—Chutes & Ladders

May 30, 2025 8:30am

paramotor forest Poland

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Nov 3, 2023 9:30am

parachute skydiving

Novavax CEO to retire after 12 years—Chutes & Ladders

Jan 13, 2023 9:30am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am